Abstract
The analysis and the value of geometrical and hemodynamic parameters of heart cavities was
performed. It allowed to determine the definite principles of their changes depending on the type
of implanted prosthesis. 267 patients aged 52.4±12.2 with congenital pathology of mitral valve
were included. All patients were divided into two groups depending on the type of implanted
prosthesis: the first group (102 patients) with bicuspid prostheses (MedInzh, ATS, Carbomedics,
On-X) and the second group (165 patients) with disk prostheses (MIKS). The comparative
analysis of structural-geometrical parameters of heart cavities and their volumes was performed
before the operation and in different terms after operative treatment during 3 years. Statistically
reliable correlation was identified (p<0.05) for intensity in positive remodeling of heart cavities,
depending on the constructive type of mechanic prosthesis in mitral position.
References
1. Бенделиани, Н. Г. Влияние оптимизированной многофакторной программы лечения больных с выраженной хронической сердечной недостаточностью на качество их жизни: дис. … канд. мед. наук. - М., 2002. - 125 с.
2. Бокерия, Л. А. Ишемическая болезнь сердца у больных с низкой сократительной способностью миокарда левого желудочка (диагностика, тактика, лечение) / Л. А. Бокерия, В. С. Работников, Ю. И. Бузиашвили и др. - М., 2001. - 195 c.
3. Бокерия, Л. А. Повторные операции у больных ишемической болезнью сердца. Современное состояние проблемы (метаанализ) / Л. А. Бокерия, И. И. Беришвили, И. В. Солнышков и др. // Бюллетень НЦССХ им. А. Н. Бакулева РАМН. - 2009. - Т. 10, № 3.
4. Бокерия, Л. А. Хирургическое лечение постинфарктной аневризмы сердца: прошлое, настоящее и будущее / Л. А. Бокерия, В. С. Работников, М. М. Алшибая, А. В. Дорофеев // Анналы хир. - 2002. - № 3. - C. 23-31.
5. Бокерия, О. Л. Ресинхронизационная терапия при застойной сердечной недостаточности - мнение экспертов и предварительные результаты последних рандомизированных исследований / О. Л. Бокерия // Анналы аритмол. - 2006. - № 1. - C. 11-21.
6. Все о холестерине: национальный доклад / Под ред. акад. РАМН Л. А. Бокерия, акад. РАМН Р. Г. Оганова. - М., 2010. -180 с.
7. Шацкий, А. С. Предикторы сердечной недостаточности и летальности при хирургической коррекции постинфарктных аневризм сердца // Бюллетень НЦССХ им. А. Н. Бакулева РАМН. - 2009. - T. 10, № 3. - C. 53-59.
8. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE) / CAPRIE Steering Committee // Lancet. - 1996. - Vol. 348 (9038). - P. 1329-1339.
9. Cameron, A. Bypass surgery with the internal mammary artery graft: 15 year follow-up / A. Cameron, H. G. Kemp Jr, G. E. Green // Circulation. - 1986. - Vol. 74. - P. 30-36.
10. Cavender, J. B. Effects of smoking on survival and morbidity in patients randomized to medical or surgical therapy in the Coronary Artery Surgery Study (CASS): 10-year follow-up / J. B. Cavender, W. J. Rogers, L. D. Fisher et al. // J. Amer. Coll. Cardiol. - 1992. - Vol. 20. - P. 287-294.
11. CIBIS-II Investigators and Committees. The cardiac insufficiency bisoprolol study II (CIBIS-II): A randomized trial // Lancet. - 1999. - Vol. 353. - P. 9-13.
12. Collaborative overview of randomised trials of antiplatelet therapy-I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients / Antiplatelet Trialists Collaboration // Brit. Med. J. - 1994. - Vol. 308 (6921). - P. 81-106.
13. Critchley, J. A. Smoking cessation for the secondary prevention of coronary heart disease / J. A. Critchley, S. Capewell // Cochrane Database of Systematic Reviews. - 2003. - Issue 4.- Art. №: CD003041. DOI: 10.1002/14651858.CD003041.pub2.
14. Davies, E. J. Exercise based rehabilitation for heart failure / E. J. Davies, T. Moxham, K. Rees et al. // Cochrane Database of Systematic Reviews. - 2010. - Issue 4. - Art. №: CD003331. DOI: 10.1002/14651858.CD003331.pub3.
15. Dunning, J. Coronary artery bypass grafting is associated with excellent long-term survival and quality of life: a prospective cohort study / J. Dunning, J. R. Waller, B. Smith et al. // Ann. Thorac. Surg. - 2008. - Vol. 85, № 6. - P. 1988-1993.
16. Ezekowitz, J. A. Aldosterone blockade and left ventricular dysfunction: a systematic review of randomized clinical trials / J. A. Ezekowitz, F. A. McAlister // Eur. Heart J. - 2009. - Vol. 30. - P. 469-477.
17. Faris, R. Diuretics for heart failure / R. Faris, M. D. Flather, H. Purcell et al. // Cochrane Database Syst. Rev. - 2006. - № 1: CD003838.
18. Fito, M. Effect of a traditional Mediterranean diet on lipoprotein oxidation: a randomized controlled trial / M. Fito, M. Guzens, D. Corella et al. // Arch. Intern. Med. - 2007. - Vol. 167. - P. 1195-1203.
19. Fitzgibbon, G. M. Coronary bypass graft fate and patient outcome: angiographic follow-up of 5,065 grafts related to survival and reoperation in 1,388 patients during 25 years / G. M. Fitzgibbon, H. P. Kafka, A. J. Leach et al. // J. Amer. Coll. Cardiol. - 1996. - Vol. 28. - P. 616-626.
20. Fox, K. M. Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study) // Lancet. - 2003. - Vol. 362. - P. 782-788.
21. Freemantle, N. Beta-blockade after myocardial infarction: systematic review and meta regression analysis / N. Freemantle, J. Cleland, P. Young et al. // BMJ. - 1999. - Vol. 318. - P. 1730-1737.
22. Garg, R. Overview of randomized trials of angiotensin- converting enzyme inhibitors on mortality and morbidity in patients with heart failure / R. Garg, S. Yusuf // JAMA. - 1995. - Vol. 273. - P. 1450-1456.
23. Grundy, S. M. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines / S. M. Grundy, J. I. Cleeman, C. N. Merz et al. // Circulation. - 2004. - Vol. 110. - P. 227-239.
24. Held, P. H. Effects of
25. Jolliffe, J. A. Exercise-based rehabilitation for coronary heart disease / J. A. Jolliffe, K. Rees, R. S. Taylor et al. // Cochrane Database Syst. Rev. - 2001. - CD001800.
26. Kim, D. H. Aspirin and clopidogrel use in the early postoperative period following on-pump and offpump coronary artery bypass grafting / D. H. Kim, C. Daskalakis, S. C. Silvestry et al. // J. Thorac. Cardiovasc. Surg. - 2009. - Vol. 138, № 6. - P. 1377-1384.
27. Knatterud, G. L. Long-term effects on clinical outcomes of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation in the Post Coronary Artery Bypass Graft Trial / G. L. Knatterud, Y. Rosenberg, L. Campeau et al. // Circulation. - 2000. - Vol. 102. - P. 157-165.
28. Lie, J. T. Aortocoronary bypass saphenous vein graft atherosclerosis: anatomic study of 99 vein grafts from normal and hyperlipoproteinemic patients up to 75 months postoperatively / J. T. Lie, G. M. Lawrie, G. C. Morris // Amer. J. Cardiol. - 1977. - Vol. 40. - P. 906-914.
29. McKelvie, R. S. Comparison of candesartan, enalapril and their combination in congestive heart failure: Randomized evaluation of strategies for left ventricular dysfunction (RESOLVD) pilot study / R. S. McKelvie, S. Yusuf, D. Pericak et al. // Circulation. - 1999. - Vol. 100. - P. 1056-1064.
30. MERIT-HF Study Group. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERITHF) // Lancet. - 1999. - Vol. 353. - P. 2001-2007.
31. Nissen, S. E. Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial / S. E. Nissen, E. M. Tuzcu, P. Schoenhagen et al. // JAMA. - 2004. - Vol. 291, № 9. - P. 1071-1080.
32. Nissen, S. E. Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial / S. E. Nissen, S. J. Nicholls, I. Sipahi et al. // JAMA. - 2006. - Vol. 295, № 13. - P. 1556-1565.
33. Packer, M. Effect of carvedilol on survival in sever chronic heart failure (COPERNICUS) // M. Packer, A. J. S. Coats, M. B. Fowler et al. // N. Engl. J. Med. - 2001. - Vol. 344. - P. 1651-1658.
34. Pearson, T. Ezetimibe added to statin therapy reduces LDL-C and improves goal attainment in patients with hypercholesterolemia / T. Pearson, M. Denke, P. McBride et al. // Program and abstracts from the American College of Cardiology 53rd Annual Scientific Session. - New Orleans, Louisiana, 2004.
35. Pitt, B. The Captopril-Digoxin Multicenter Research Group study on the comparative steps of captopril and digoxin in patients with mild-moderate heart failure: implications for therapy / B. Pitt, S. Goldstein // Cardiovasc. Drugs Ther. - 1989. - Vol. 3, № 1. - P. 7-9.
36. Schmuziger, M. Reoperative myocardial revascularization: an analysis of 458 reoperations and 2645 single operations / M. Schmuziger, J. T. Christenson, J. Maurice et al. // J. Cardiovasc. Surg. - 1994. - Vol. 2, № 5. - P. 623-629.
37. Shah, S. J. Intensive lipid-lowering with atorvastatin for secondary prevention in patients after coronary artery bypass surgery / S. J. Shah, D. D. Waters, P. Barter et al. // J. Amer. Coll. Cardiol. - 2008. - Vol. 51, № 20. - P. 1938-1943.
38 Shapira, O. M. Nitroglycerin is preferable to diltiazem for prevention of coronary bypass conduit spasm / O. M. Shapira, J. D. Alkon, D. S. Macron et al. // Ann. Thorac. Surg. - 2000. - Vol. 70, № 3. - P. 883-888.
39. Squizzato, A. Clopidogrel plus aspirin versus aspirin alone for preventing cardiovascular disease / A. Squizzato, T. Keller, S. Middeldorp // Cochrane Database of Systematic Reviews. - 2007. - Issue 3. - Art. №: CD005158. DOI: 10.1002/14651858. CD005158.pub2.
40. Swedberg, K. Candesartan in heart failure-assessment of reduction in mortality (CHARM): rationale and design / K. Swedberg, M. Pfeffer, C. Granger et al. // J. Card. Fail. - 1999. - Vol. 5. - P. 276-282.
41. The CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS) // N. Engl. J. Med. - 1987. - Vol. 316, № 23. - P. 1429-1435.
42. The Digitalis Investigation Group. The effect of digoxin on mortality and morbidity in patients with heart failure // N. Engl. J. Med. - 1997. - Vol. 336, № 8. - P. 525-533.
43. The PEACE Trial Investigators. Angiotensinconverting- enzyme inhibition in stable coronary artery disease // N. Engl. J. Med. - 2004. - Vol. 351.- P. 2058-2068.
44. The RALES Investigators. Effectiveness of spironolactone added to an angiotensinconverting enzyme inhibitor and a loop diuretic for severe chronic congestive heart failure (the Randomized Aldactone Evaluation Study [RALES]) // Amer. J. Cardiol. - 1996. - Vol. 78. - P. 902-907.
45. The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure // N. Engl. J. Med. - 1991. - Vol. 325. - P. 293-302.
46. Velazquez, E. J. An international perspective on heart failure and left ventricular systolic dysfunction complicating myocardial infarction: the VALIANT registry / E. J. Velazquez, G. S. Francis, P. W. Armstrong et al. // Eur. Heart J. - 2004. - Vol. 25, № 21. - P. 1911-1919.
47. Yusuf, S. Effects of an angiotensin-convertingenzyme inhibitor, ramipril, on cardiovascular events in high-risk patients / S. Yusuf, P. Sleight, J. Pogue et al. // N. Engl. J. Med. - 2000. - Vol. 342. - P. 145-153.
48. Zaiac, M. Coronary artery spasm following coronary artery bypass grafting. Treatment with intracoronary ISDN followed by systemic intravenous nifedipine infusion / M. Zaiac, A. Renzulli, C. J. Hilton // Eur. J. Cardiothorac. Surg. - 1990. - Vol. 4, № 2. - P. 109-111.
